Pfizer, Boehringer’s Drug Helped to Delay Asthma Attacks

A lung drug from Boehringer Ingelheim and Pfizer helped delay severe episodes in asthma patients, researchers said in two studies that may result in broader use of the medicine.
Bloomberg